PAA

2.63%

19.5¢ pharmaust limited

Ann: Board Changes, page-167

First 167 Last

Share
Profile

Follow
aboo

569 Posts.

142

10/05/24

21:35

Post #: 73772091
Share

Originally posted by Densy: ↑

All –

Apologies for the lateness of this post. I’ve been busy in the real world!

Some very interesting and, IMO, positive developments this week.

New blood appointed to the BoD – I’m waiting now to see what remains to unfold and what communications are issued once they have had the opportunity to meet.I’m expecting that there will be further developments in the near term to address a range of issues that have been raised by SH for several years. If this doesn’t occur, the option for further action to be taken by members of the Company is still alive.

Interim arrangements include John Clark joining the BoD and continuing to act as CEO – I think we should all do whatever we can to lend our support to John, who has stepped up for the Company (that’s US people) at a very challenging time. I hope that the BoD has turned its mind to the need to support John in whatever way it can.

For those who are disappointed that the restructuring of the BoD has been accompanied by a SP drop, I urge patience and a longer-term view of the situation. I remain confident that these structural reforms to the way the Company is governed are not only necessary but will set us up well to transition from baby-biotech to world beater. From what I have learnt over the past week, I believe this would not and could not have happened without these significant reforms.

The current SP presents an outstanding buying opportunity as the company fundamentals have not changed – other than the obvious reinvigoration of the Board with new Directors who are well equipped to guide PAA through the next exciting stage.

The changes that occurred this week were never going to be a magic wand – they are the start of a very exciting journey and I look forward to being aboard for the next chapter.

Cheers

Densy

Expand

thanks @Densy

I remain patient. as you know it's a (now) 11 year ride for me.

looking forward to the next couple of weeks as things settle down a little.

PAA Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 84 more messages in this thread...

First 167 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $94.89M

Open	High	Low	Value	Volume
19.0¢	19.5¢	19.0¢	$58.40K	305.6K

Buyers (Bids)

No.	Vol.	Price($)
2	115000	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
19.5¢	86074	3

View Market Depth

No.	Vol.	Price($)
2	115000	0.190
8	156232	0.185
10	635662	0.180
10	482365	0.175
8	151233	0.170

Price($)	Vol.	No.
0.195	86074	3
0.200	256824	3
0.205	113150	5
0.210	333355	8
0.215	266995	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PAA (ASX) Chart

Ann: Board Changes, page-167

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Board Changes, page-167

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News